SAN FRANCISCO, CA –
Canopy Financial, a pioneer in innovative
technology solutions that connect healthcare and financial services,
announced today the results of its
for Q3′08. Canopy, whose industry leading
respectively, collects and aggregates a wide range of statistics
related to actual HSA usage published quarterly. In Q3′08, despite sharp
drops in U.S. financial markets, Individual and Family HSA accounts showed
only modest declines Read the rest of this entry »

SNTS.O
), a specialty
pharmaceutical company, said U.S. health regulators declined to
approve the marketing application for the over-the-counter
version of its heartburn drug Zegerid submitted by partner
Schering-Plough Corp (
SGP.N
).
The company said Schering received a “complete response”
letter, which outlined questions that the U.S. Food and Drug
Administration identified during its review of the new drug
application for OTC Zegerid.
Read the rest of this entry »

Jan. 28 (Bloomberg) –
, the largest U.S.
health insurer by enrollment, missed estimates for fourth-quarter
earnings and gave no profit forecast as bad investments, computer
errors and a shrinking job market sapped income.
Net income fell 61 percent from a year earlier to $331.4
million, or 65 cents a share, the Indianapolis-based company said
today in a statement. Profit excluding investment losses and
other items missed by 2 cents the $1.36 Read the rest of this entry »

HOHHOT, China (AFP) — China on Tuesday declined to release updated figures revealing how many children have been affected by the tainted milk scandal, as it attempted to boost confidence in its food safety standards.
The health ministry said it had new statistics showing how many babies were believed to have been left ill by the crisis, but did not release the data and gave no indication if or when it would make the latest information public.
Read the rest of this entry »

Dec 9 (Reuters) – Targanta Therapeutics Corp (TARG.O:
,
,
,
) said
the U.S. health regulators declined to approve its antibiotic,
oritavancin, as its application did not show safety or efficacy
of the drug in the treatment of complicated skin and skin
structure infections (cSSSI).
The U.S. Food and Drug Administration (FDA) has asked the
company to perform an additional clinical study to demonstrate
efficacy and safety of the drug, Targanta Read the rest of this entry »

WellPoint's Profit Declines 5.4% on Bad Investments (Update1)
Oct. 22 (Bloomberg) –
, the health insurer
for one of every nine Americans, said third-quarter profit fell
5.4 percent, dragged down by investments that went bad in the
credit crisis.
Net income decreased to $820.7 million, or $1.60 a share,
from $868 million, or $1.45, a year earlier, the Indianapolis-
based company said today in a statement. The company reduced the
upper range Read the rest of this entry »

(RTTNews) - 
Tuesday, Utah Medical Products, Inc. (UTMD:
), a manufacturer of disposable and reusable specialty medical devices, reported a decline in fourth quarter earnings, hurt by a 6.8% decline in sales, impacted by the overall economic slow down.
The Salt Lake City, Utah-based company reported net income for the fourth quarter of $1.58 million or $0.42 per share, down from $1.96 million or $0.49 per share Read the rest of this entry »

Availability Of EC For Teens Declines At NYC Health Clinics, Report Says
The number of teen health clinics in New York City offering same-day pick up of emergency contraception dropped by 13% from 2007 to 2008, according to a
released Monday by New York City Public Advocate Betsy Gotbaum, the
reports. The report surveyed the 38 teen health clinics in the city in June and found that 10 of them had EC available, compared with 15 clinics in a 2007 Read the rest of this entry »

WellPoint's Profit Declines 5.4% on Bad Investments (Update3)
Oct. 22 (Bloomberg) –
, the health insurer
for one of every nine Americans, said third-quarter profit fell
5.4 percent, dragged down by bad investments in
,
The company dropped as much as 4.4 percent in New York
trading today after reporting investment losses of $562.6
million, or 71 cents a share. Chief Executive Officer
said more writedowns may be taken in the fourth quarter,
and Read the rest of this entry »

Jan. 28 (Bloomberg) –
, the largest U.S.
health insurer by enrollment, missed estimates for fourth-quarter
earnings and gave no detailed profit forecast as bad investments,
computer errors and a shrinking job market sapped income.
Net income fell 61 percent from a year earlier to $331.4
million, or 65 cents a share, the Indianapolis-based company said
today in a statement. Profit excluding investment losses and
other items missed by 2 cents the Read the rest of this entry »